Literature DB >> 15309898

Impaired rectoanal inhibitory response in scleroderma (systemic sclerosis): an association with fecal incontinence.

Gregory J Heyt1, Mina K Oh, Nazanin Alemzadeh, Susie Rivera, Sergio A Jimenez, Satish Rattan, Sidney Cohen, Anthony J Dimarino.   

Abstract

Gastrointestinal abnormalities in systemic sclerosis (SSc) involve both myogenic and neural mechanisms. The aims of this study were to evaluate the rectoanal inhibitory response (RAIR) in SSc patients and to correlate RAIR with duration and subtype of disease, antibody status, and lower gastrointestinal symptoms. Thirty-five patients with SSc completed a questionnaire and underwent anorectal manometry (ARM). Forty-five patients without SSc served as controls. In the 35 SSc patients, 62.3% reported diarrhea, 57.1% reported constipation, and 37.1% reported fecal incontinence. Twenty-five of the 35 scleroderma patients (71.4%) demonstrated an impaired or absent RAIR, compared with none of the 45 controls (P < 0.001). Eleven of 13 incontinent SSc patients (84%) had an impaired RAIR. No correlation was found between RAIR and duration or subtype of SSc, antibody status, or presence of diarrhea or constipation. Impaired RAIR was closely correlated with fecal incontinence, suggesting a possible neural mechanism for maintenance of continence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15309898     DOI: 10.1023/b:ddas.0000034569.85066.69

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  SCLERODERMA OF THE ESOPHAGUS. A CORRELATION OF HISTOLOGIC AND PHYSIOLOGIC FINDINGS.

Authors:  W L TREACY; A H BAGGENSTOSS; C H SLOCUMB; C F CODE
Journal:  Ann Intern Med       Date:  1963-09       Impact factor: 25.391

2.  CONTRIBUTION OF THE EXTERNAL ANAL SPHINCTER TO THE PRESSURE ZONE IN THE ANAL CANAL.

Authors:  H L DUTHIE; J M WATTS
Journal:  Gut       Date:  1965-02       Impact factor: 23.059

Review 3.  Gastrointestinal manifestations of scleroderma.

Authors:  S Rose; M A Young; J C Reynolds
Journal:  Gastroenterol Clin North Am       Date:  1998-09       Impact factor: 3.806

4.  Function of the anal sphincters in spinal man.

Authors:  B Frenckner
Journal:  Gut       Date:  1975-08       Impact factor: 23.059

5.  Fecal incontinence in scleroderma. Clinical features, anorectal manometric findings, and their therapeutic implications.

Authors:  B W Jaffin; P Chang; H Spiera
Journal:  J Clin Gastroenterol       Date:  1997-10       Impact factor: 3.062

6.  Autonomic nervous system and smooth muscle cell involvement in systemic sclerosis: ultrastructural study of 3 cases.

Authors:  A Malandrini; E Selvi; M Villanova; G Berti; L Sabadini; C Salvadori; S Gambelli; R De Stefano; R Vernillo; R Marcolongo; G Guazzi
Journal:  J Rheumatol       Date:  2000-05       Impact factor: 4.666

7.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

8.  Anorectal dysfunction and delayed colonic transit in patients with progressive systemic sclerosis.

Authors:  G Basilisco; R Barbera; M Vanoli; P Bianchi
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

9.  Progressive systemic sclerosis of the internal anal sphincter leading to passive faecal incontinence.

Authors:  A F Engel; M A Kamm; I C Talbot
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

10.  The gastrointestinal manifestations of scleroderma: pathogenesis and management.

Authors:  S Cohen
Journal:  Gastroenterology       Date:  1980-07       Impact factor: 22.682

View more
  18 in total

Review 1.  Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis.

Authors:  S Kumar; J Singh; S Rattan; A J DiMarino; S Cohen; S A Jimenez
Journal:  Aliment Pharmacol Ther       Date:  2017-02-09       Impact factor: 8.171

2.  Role of muscarinic-3 receptor antibody in systemic sclerosis: correlation with disease duration and effects of IVIG.

Authors:  Sumit Kumar; Jagmohan Singh; Ramalinga Kedika; Fabian Mendoza; Sergio A Jimenez; Erik S Blomain; Anthony J DiMarino; Sidney Cohen; Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-05-12       Impact factor: 4.052

Review 3.  Gastrointestinal and Hepatic Disease in Systemic Sclerosis.

Authors:  Tracy M Frech; Diane Mar
Journal:  Rheum Dis Clin North Am       Date:  2018-02       Impact factor: 2.670

4.  Gastrointestinal manifestations in Hungarian scleroderma patients.

Authors:  Szilvia Szamosi; Zoltán Szekanecz; Gabriella Szucs
Journal:  Rheumatol Int       Date:  2006-06-13       Impact factor: 2.631

5.  Gastrointestinal Manifestations of Systemic Sclerosis.

Authors:  Andrew B Shreiner; Charles Murray; Christopher Denton; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2016-10-18

6.  BDNF augments rat internal anal sphincter smooth muscle tone via RhoA/ROCK signaling and nonadrenergic noncholinergic relaxation via increased NO release.

Authors:  Arjun Singh; Ipsita Mohanty; Jagmohan Singh; Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-11-04       Impact factor: 4.052

7.  Gastric dysmotility after liquid bolus ingestion in systemic sclerosis: an ultrasonographic study.

Authors:  Franco Cozzi; Giancarlo Parisi; Luca Ciprian; Arianna Bullo; Silvia Cardarelli; Michela Rizzo; Paolo Sfriso; Leonardo Punzi
Journal:  Rheumatol Int       Date:  2011-01-22       Impact factor: 2.631

8.  Clinical Assessment of Gastrointestinal Involvement in Patients with Systemic Sclerosis.

Authors:  Timothy Kaniecki; Tsion Abdi; Zsuzsanna H McMahan
Journal:  Med Res Arch       Date:  2020-10-29

9.  Discriminative value of anorectal manometry in clinical practice.

Authors:  Naeem Raza; Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2008-12-18       Impact factor: 3.199

Review 10.  Points to consider for clinical trials of the gastrointestinal tract in systemic sclerosis.

Authors:  Daniel E Furst; Yolanda Braun-Moscovic; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.